loceryl has been researched along with terbinafine in 48 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 6 (12.50) | 18.2507 |
| 2000's | 16 (33.33) | 29.6817 |
| 2010's | 24 (50.00) | 24.3611 |
| 2020's | 2 (4.17) | 2.80 |
| Authors | Studies |
|---|---|
| Juvonen, RO; Koskiranta, J; Ollakka, R; Rahnasto-Rilla, M; Raunio, H; Ritvanen, A; Salminen, KA; Tani, N; Wittekindt, C | 1 |
| Gupta, AK; Sauder, DN; Shear, NH | 1 |
| Hoeprich, PD | 1 |
| Hiratani, T; Yamaguchi, H | 1 |
| Clayton, YM | 1 |
| Favre, B; Ryder, NS | 1 |
| Cork, MJ; Haycox, A; Humphrey, KM | 1 |
| Badillet, G; Baran, R; Combernale, P; Czernielewski, J; Datry, A; Feuilhade, M; Goettmann, S; Larnier, C; Pietrini, P; Viguie, C | 1 |
| Baran, R | 1 |
| Evans, EG | 1 |
| Kakehi, K; Senda, H; Tatsumi, Y; Yokoo, M | 1 |
| Ito, T; Majima, T; Nakashima, T; Nozawa, A | 1 |
| Austel, U | 1 |
| Reinel, D | 1 |
| Galhardo, MC; Oliveira, LA; Reis, RS; Valle, AC; Wanke, B | 1 |
| Ratajczak-Stefańska, V | 1 |
| Macura, AB; Pawlik, B; Szczepko, I | 1 |
| Jäckel, A; Neubert, RH; Schmelzer, CE; Wartewig, S | 1 |
| Baran, R; de Berker, D; Faergemann, J; Kaufmann, R; Kerrouche, N; Lecha, M; Sidou, F; Sigurgeirsson, B | 1 |
| Carrillo-Muñoz, AJ; Del Valle, O; Eraso, E; Ezkurra, PA; Giusiano, G; Guardia, C; Hernández-Molina, JM; Quindós, G; Santos, P; Tur-Tur, C | 1 |
| Cantrell, W; Cathcart, S; Elewski, Be | 1 |
| Budihardja, D; Freund, V; Mayser, P | 1 |
| Katoh, T | 1 |
| Kerrouche, N; Olafsson, JH; Sidou, F; Sigurgeirsson, B; Steinsson, JT | 1 |
| Baudraz-Rosselet, F; Bontems, O; Lurati, M; Monod, M; Ruffieux, C | 1 |
| Piraccini, BM; Sisti, A; Tosti, A | 1 |
| Vera-Cabrera, L; Welsh, E; Welsh, O | 1 |
| Brown, MB; Evans, CR; Jones, SA; Khengar, RH; Traynor, MJ; Turner, RB | 1 |
| Fothergill, A; Jo Siu, WJ; Nakamura, T; Pillai, R; Senda, H; Sone, D; Tatsumi, Y | 1 |
| Arendrup, MC; Haugaard, LK; Saunte, DM; Skov, L | 1 |
| Lipner, S; Scher, RK | 1 |
| Bulgheroni, A; Celandroni, F; Ghelardi, E; Gueye, SA; Mailland, F; Salvetti, S; Senesi, S | 1 |
| Fothergill, AW; McCarthy, DI; Tavakkol, A; Wiederhold, NP | 1 |
| Auvinen, T; Jokinen, JJ; Sipponen, A; Soini, M; Tiihonen, R; Wangel, M | 1 |
| Hilton, S; Kerai, LV; Murdan, S | 1 |
| Borelli, C; Jäckel, A; Müller, J; Polak, A; Schaller, M; Seidl, HP | 1 |
| Hossin, B; Murdan, S; Rizi, K | 1 |
| Bhatia, N; Caldwell, B; Elewski, BE; Gupta, AK; Kircik, LH; Pariser, DM; Rosen, T; Tosti, A | 1 |
| Brown, MB; Guesné, S; Jones, SA; McAuley, WJ; Murdan, S; Traynor, MJ | 1 |
| Brown, M; Kondori, N; Stensen, W; Svendsen, JS; Svenson, J; Turner, R | 1 |
| Feng, X; Ran, Y; Xiong, X | 1 |
| Eichenfield, LF; Friedlander, SF | 1 |
| Chakrabarti, A; Dogra, S; Mushtaq, K; Narang, T; Paul, RA; Rudramurthy, SM; Shankarnarayan, SA; Shaw, D | 1 |
| Bardés, J; Hilton, S; Kerai, LV; Murdan, S | 1 |
| He, Y; Tan, J; Yang, L; Zhang, J | 1 |
| Ghannoum, M; Kunze, G; Long, L; Osman-Ponchet, H; Sarkany, M | 1 |
| Harada, K; Inagaki, K; Kampirapap, K; Koga, H; Maeda, J; Makimura, K; Nanjoh, Y; Neki, D; Reangchainam, S; Tsuboi, R; Yuasa, K | 1 |
| Blume-Peytavi, U; Carreño, C; Falqués, M; Galván, J; Tamarit, ML; Tebbs, V; Tosti, A | 1 |
9 review(s) available for loceryl and terbinafine
| Article | Year |
|---|---|
Antifungal agents: an overview. Part II.
Topics: Allylamine; Antifungal Agents; Azoles; Dermatomycoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 1994 |
Antifungal chemotherapy.
Topics: Amphotericin B; Antifungal Agents; Fluconazole; Flucytosine; Itraconazole; Ketoconazole; Morpholines; Naphthalenes; Terbinafine | 1995 |
The rationale for combination therapy.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Arthrodermataceae; Cell Wall; Drug Therapy, Combination; Ergosterol; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Recurrence; Terbinafine | 2001 |
Onychomycosis and diabetes.
Topics: Administration, Topical; Antifungal Agents; Ciclopirox; Diabetes Complications; Humans; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2009 |
Toenail onychomycosis in diabetic patients: issues and management.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Ciclopirox; Comorbidity; Diabetes Mellitus; Diabetic Foot; Drug Interactions; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Risk Factors; Terbinafine; Therapies, Investigational; Treatment Outcome | 2009 |
[Guidelines for diagnosis and treatment of mucocutaneous candidiasis].
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Candida albicans; Candidiasis, Chronic Mucocutaneous; Drug Administration Schedule; Humans; Imidazoles; Ketoconazole; Microscopy; Morpholines; Naphthalenes; Practice Guidelines as Topic; Terbinafine | 2009 |
Onychomycosis.
Topics: Administration, Cutaneous; Administration, Oral; Antifungal Agents; Ciclopirox; Drug Administration Schedule; Drug Therapy, Combination; Fluconazole; Foot Dermatoses; Humans; Itraconazole; Mitosporic Fungi; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Pyrimidines; Terbinafine; Thiazoles; Triazoles; Voriconazole | 2010 |
Efficacy and tolerability of amorolfine 5% nail lacquer in combination with systemic antifungal agents for onychomycosis: A meta-analysis and systematic review.
Topics: Administration, Topical; Antifungal Agents; Drug Therapy, Combination; Humans; Itraconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2017 |
Pediatric Onychomycosis: The Emerging Role of Topical Therapy.
Topics: Administration, Topical; Adult; Age Factors; Antifungal Agents; Child; Ciclopirox; Family; Humans; Imidazoles; Incidence; Ketoconazole; Lacquer; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Pyridones; Recurrence; Terbinafine; Tinea Pedis; Treatment Outcome | 2017 |
7 trial(s) available for loceryl and terbinafine
| Article | Year |
|---|---|
A randomized trial of amorolfine 5% solution nail lacquer combined with oral terbinafine compared with terbinafine alone in the treatment of dermatophytic toenail onychomycoses affecting the matrix region.
Topics: Adult; Antifungal Agents; Cost-Benefit Analysis; Drug Synergism; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Terbinafine; Treatment Outcome | 2000 |
Topical amorolfine for 15 months combined with 12 weeks of oral terbinafine, a cost-effective treatment for onychomycosis.
Topics: Administration, Oral; Administration, Topical; Antifungal Agents; Cost-Benefit Analysis; Drug Costs; Drug Therapy, Combination; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2001 |
[Assessment of mycological and clinical factors on the course and results of treatment of mycotic infections in patients with recurrent onychomycosis].
Topics: Adolescent; Adult; Aged; Drug Therapy, Combination; Epidermophyton; Humans; Itraconazole; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pentoxifylline; Recurrence; Terbinafine; Treatment Outcome; Trichophyton | 2003 |
A multicentre, randomized, controlled study of the efficacy, safety and cost-effectiveness of a combination therapy with amorolfine nail lacquer and oral terbinafine compared with oral terbinafine alone for the treatment of onychomycosis with matrix invol
Topics: Administration, Oral; Administration, Topical; Adolescent; Adult; Aged; Antifungal Agents; Cost-Benefit Analysis; Drug Therapy, Combination; Female; Hand Dermatoses; Humans; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Terbinafine | 2007 |
Efficacy of amorolfine nail lacquer for the prophylaxis of onychomycosis over 3 years.
Topics: Administration, Oral; Administration, Topical; Adult; Aged; Antifungal Agents; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Longitudinal Studies; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Pilot Projects; Secondary Prevention; Terbinafine; Treatment Outcome | 2010 |
Efficacy of topical resin lacquer, amorolfine and oral terbinafine for treating toenail onychomycosis: a prospective, randomized, controlled, investigator-blinded, parallel-group clinical trial.
Topics: Administration, Oral; Administration, Topical; Adult; Antifungal Agents; Drug Administration Schedule; Drug Therapy, Combination; Female; Foot Dermatoses; Humans; Lacquer; Male; Morpholines; Naphthalenes; Onychomycosis; Prospective Studies; Resins, Plant; Single-Blind Method; Terbinafine; Treatment Outcome; Young Adult | 2015 |
A multicentre, randomised, parallel-group, double-blind, vehicle-controlled and open-label, active-controlled study (versus amorolfine 5%), to evaluate the efficacy and safety of terbinafine 10% nail lacquer in the treatment of onychomycosis.
Topics: Antifungal Agents; Double-Blind Method; Foot Dermatoses; Humans; Lacquer; Morpholines; Nails; Onychomycosis; Terbinafine; Treatment Outcome | 2022 |
32 other study(ies) available for loceryl and terbinafine
| Article | Year |
|---|---|
Antifungal activities of novel non-azole molecules against S. cerevisiae and C. albicans.
Topics: Antifungal Agents; Candida albicans; Drug Design; Drug Evaluation, Preclinical; Enzyme Inhibitors; Humans; Liver; Models, Molecular; Nitriles; Protein Conformation; Saccharomyces cerevisiae; Sterol 14-Demethylase; User-Computer Interface | 2012 |
[Cross-resistance of Candida albicans to several different families of antifungals with ergosterol biosynthesis-inhibiting activity].
Topics: Antifungal Agents; Candida albicans; Depression, Chemical; Drug Resistance, Microbial; Ergosterol; Ketoconazole; Morpholines; Naphthalenes; Terbinafine; Triazoles | 1994 |
Relevance of broad-spectrum and fungicidal activity of antifungals in the treatment of dermatomycoses.
Topics: Antifungal Agents; Arthrodermataceae; Itraconazole; Microbial Sensitivity Tests; Mitosporic Fungi; Morpholines; Naphthalenes; Terbinafine | 1994 |
Characterization of squalene epoxidase activity from the dermatophyte Trichophyton rubrum and its inhibition by terbinafine and other antimycotic agents.
Topics: Antifungal Agents; Candida albicans; Chromatography, Thin Layer; Enzyme Inhibitors; Morpholines; Naphthalenes; Oxygenases; Squalene Monooxygenase; Terbinafine; Thiocarbamates; Trichophyton | 1996 |
A retrospective cost-effectiveness analysis of the treatment of onychomycosis in general practice.
Topics: Antifungal Agents; Cost-Benefit Analysis; England; Family Practice; Griseofulvin; Humans; Imidazoles; Morpholines; Naphthalenes; Onychomycosis; Referral and Consultation; Retrospective Studies; Terbinafine | 1998 |
Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
Topics: Administration, Oral; Administration, Topical; Animals; Antifungal Agents; Guinea Pigs; Male; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Tinea Pedis; Triazoles; Trichophyton | 2002 |
Experimental tinea unguium model to assess topical antifungal agents using the infected human nail with dermatophyte in vitro.
Topics: Adult; Antifungal Agents; Female; Humans; Imidazoles; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridines; Terbinafine; Thiones; Trichophyton | 2002 |
[Dual therapy of onychomycoses. Only Schwaben Province physicians also think of costs].
Topics: Administration, Topical; Antifungal Agents; Cost Control; Drug Costs; Drug Therapy, Combination; Germany; Humans; Morpholines; Naphthalenes; National Health Programs; Onychomycosis; Terbinafine | 2003 |
[Onychomycosis].
Topics: Antifungal Agents; Ciclopirox; Debridement; Diagnosis, Differential; Drug Therapy, Combination; Fluconazole; Griseofulvin; Humans; Imidazoles; Itraconazole; Morpholines; Mycological Typing Techniques; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Time Factors | 2004 |
Disseminated dermatophytosis caused by Microsporum gypseum in an AIDS patient: response to terbinafine and amorolfine.
Topics: Acquired Immunodeficiency Syndrome; Adult; AIDS-Related Opportunistic Infections; Antifungal Agents; Dermatomycoses; Humans; Male; Microsporum; Morpholines; Naphthalenes; Terbinafine; Treatment Outcome | 2004 |
[The susceptibility of Aspergillus and Penicillium to recent antimycotics].
Topics: Antifungal Agents; Aspergillus; Ciclopirox; Drug Resistance, Fungal; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Penicillium; Pyridones; Terbinafine | 2000 |
Sublimation of antimycotic agents as proved by various analytical methods.
Topics: Anti-Infective Agents, Local; Antifungal Agents; Chromatography, High Pressure Liquid; Excipients; Mass Spectrometry; Morpholines; Naphthalenes; Spectrometry, Mass, Electrospray Ionization; Spectroscopy, Fourier Transform Infrared; Terbinafine | 2006 |
In vitro antifungal activity of sertaconazole nitrate against recent isolates of onychomycosis causative agents.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dose-Response Relationship, Drug; Fluconazole; Fungi; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Thiophenes; Yeasts | 2008 |
Onychomycosis insensitive to systemic terbinafine and azole treatments reveals non-dermatophyte moulds as infectious agents.
Topics: Acremonium; Adult; Antifungal Agents; Aspergillus; Female; Fluconazole; Foot Dermatoses; Fusarium; Humans; Itraconazole; Male; Middle Aged; Morpholines; Naphthalenes; Onychomycosis; Polymorphism, Restriction Fragment Length; Terbinafine | 2010 |
Long-term follow-up of toenail onychomycosis caused by dermatophytes after successful treatment with systemic antifungal agents.
Topics: Adult; Aged; Antifungal Agents; Arthrodermataceae; Female; Foot Dermatoses; Humans; Itraconazole; Lacquer; Male; Middle Aged; Morpholines; Nails; Naphthalenes; Onychomycosis; Prospective Studies; Recurrence; Terbinafine; Treatment Outcome | 2010 |
Effect of a novel penetration enhancer on the ungual permeation of two antifungal agents.
Topics: Adenosine Triphosphate; Administration, Topical; Antifungal Agents; Cadaver; Ciclopirox; Humans; In Vitro Techniques; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Pyridones; Terbinafine | 2010 |
Comparison of in vitro antifungal activities of efinaconazole and currently available antifungal agents against a variety of pathogenic fungi associated with onychomycosis.
Topics: Antifungal Agents; Aspergillus; Candida; Cryptococcus; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pseudallescheria; Scopulariopsis; Terbinafine; Triazoles; Trichophyton; Trichosporon | 2013 |
[Onychomycosis is rare in young children, and treatment is a task for dermatological specialists].
Topics: Antifungal Agents; Child, Preschool; Female; Foot Dermatoses; Humans; Morpholines; Naphthalenes; Onychomycosis; Terbinafine; Treatment Outcome; Trichophyton | 2013 |
Onychomycosis: current and future therapies.
Topics: Antifungal Agents; Boron Compounds; Bridged Bicyclo Compounds, Heterocyclic; Ciclopirox; Debridement; Foot Dermatoses; Hand Dermatoses; Humans; Laser Therapy; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine; Triazoles | 2014 |
Potential of Ergosterol synthesis inhibitors to cause resistance or cross-resistance in Trichophyton rubrum.
Topics: Antifungal Agents; Ciclopirox; Drug Resistance, Fungal; Ergosterol; Itraconazole; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Pyridones; Terbinafine; Trichophyton | 2014 |
Luliconazole demonstrates potent in vitro activity against dermatophytes recovered from patients with onychomycosis.
Topics: Antifungal Agents; Arthrodermataceae; Ciclopirox; Dermatomycoses; Humans; Imidazoles; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Pyridones; Terbinafine | 2014 |
UV-curable gel formulations: Potential drug carriers for the topical treatment of nail diseases.
Topics: Administration, Topical; Antifungal Agents; Chemistry, Pharmaceutical; Drug Carriers; Drug Liberation; Ethanol; Gels; Humans; Methacrylates; Methylmethacrylates; Morpholines; Nail Diseases; Nails; Naphthalenes; Propiophenones; Pyrrolidinones; Terbinafine; Ultraviolet Rays; Urethane | 2015 |
Sporicidal effect of amorolfine and other antimycotics used in the therapy of fungal nail infections.
Topics: Antifungal Agents; Candida albicans; Ciclopirox; Epidermophyton; Fluconazole; Hand Dermatoses; Humans; Keratins; Microbial Sensitivity Tests; Morpholines; Nails; Naphthalenes; Onychomycosis; Pyridones; Spores, Fungal; Terbinafine; Trichophyton | 2015 |
Application of Hansen Solubility Parameters to predict drug-nail interactions, which can assist the design of nail medicines.
Topics: Adolescent; Adult; Antifungal Agents; Ciclopirox; Drug Interactions; Female; Humans; Keratins; Male; Middle Aged; Morpholines; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Pharmaceutical Preparations; Pyridones; Solubility; Terbinafine; Triazoles; Young Adult | 2016 |
Onychomycosis: Strategies to Minimize Recurrence.
Topics: Administration, Topical; Antifungal Agents; Comorbidity; Diabetes Mellitus; Drug Administration Schedule; Humans; Itraconazole; Morpholines; Naphthalenes; Onychomycosis; Prevalence; Recurrence; Terbinafine; Tinea Pedis; Triazoles | 2016 |
An investigation of how fungal infection influences drug penetration through onychomycosis patient's nail plates.
Topics: Administration, Topical; Antifungal Agents; Humans; Keratins; Morpholines; Mycoses; Nail Diseases; Nails; Naphthalenes; Onychomycosis; Permeability; Skin; Terbinafine; Water | 2016 |
Short Cationic Antimicrobial Peptides Display Superior Antifungal Activities toward Candidiasis and Onychomycosis in Comparison with Terbinafine and Amorolfine.
Topics: Antifungal Agents; Antimicrobial Cationic Peptides; Candida albicans; Candidiasis; Humans; Microbial Sensitivity Tests; Morpholines; Naphthalenes; Onychomycosis; Skin Diseases; Terbinafine | 2016 |
Mutation in the Squalene Epoxidase Gene of Trichophyton interdigitale and Trichophyton rubrum Associated with Allylamine Resistance.
Topics: Allylamine; Antifungal Agents; Arthrodermataceae; Ciclopirox; Drug Resistance, Fungal; Fluconazole; Itraconazole; Microbial Sensitivity Tests; Morpholines; Squalene Monooxygenase; Terbinafine; Trichophyton; Voriconazole | 2018 |
Two strategies to enhance ungual drug permeation from UV-cured films: Incomplete polymerisation to increase drug release and incorporation of chemical enhancers.
Topics: Absorption, Physiological; Administration, Topical; Adolescent; Adult; Aged; Drug Carriers; Drug Compounding; Drug Liberation; Humans; Kinetics; Mercaptoethanol; Methacrylates; Middle Aged; Morpholines; Nails; Permeability; Polyethylene Glycols; Polymerization; Polymers; Pyrrolidines; Solubility; Technology, Pharmaceutical; Terbinafine; Ultraviolet Rays; Urethane; Water; Young Adult | 2018 |
Tacrolimus, not triamcinolone acetonide, interacts synergistically with itraconazole, terbinafine, bifonazole, and amorolfine against clinical dermatophyte isolates.
Topics: Antifungal Agents; Arthrodermataceae; Dermatomycoses; Drug Synergism; Humans; Imidazoles; Immunosuppressive Agents; Itraconazole; Microbial Sensitivity Tests; Morpholines; Species Specificity; Tacrolimus; Terbinafine; Triamcinolone Acetonide | 2018 |
A pilot, layerwise, ex vivo evaluation of the antifungal efficacy of amorolfine 5% nail lacquer vs other topical antifungal nail formulations in healthy toenails.
Topics: Administration, Topical; Allylamine; Antifungal Agents; Cadaver; Ciclopirox; Humans; Lacquer; Morpholines; Nails; Pilot Projects; Terbinafine; Trichophyton | 2019 |
In vitro antifungal activity of luliconazole against nondermatophytic moulds.
Topics: Amphotericin B; Antifungal Agents; Clotrimazole; Fluconazole; Fungi; Humans; Imidazoles; Itraconazole; Ketoconazole; Miconazole; Microbial Sensitivity Tests; Morpholines; Sequence Analysis, DNA; Terbinafine; Triazoles; Voriconazole | 2020 |